57 related articles for article (PubMed ID: 10398817)
1. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques.
Nijsen JF; Zonnenberg BA; Woittiez JR; Rook DW; Swildens-van Woudenberg IA; van Rijk PP; van het Schip AD
Eur J Nucl Med; 1999 Jul; 26(7):699-704. PubMed ID: 10398817
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use.
Bakker RC; van Es RJJ; Rosenberg AJWP; van Nimwegen SA; Bastiaannet R; de Jong HWAM; Nijsen JFW; Lam MGEH
Nucl Med Commun; 2018 Mar; 39(3):213-221. PubMed ID: 29309367
[TBL] [Abstract][Full Text] [Related]
3. Development of samarium-doped phosphate glass microspheres for internal radiotheranostic applications.
Arjuna A; Milborne B; Putra AR; Mulyaningsih TR; Setiawan H; Islam MT; Felfel R; Ahmed I
Int J Pharm; 2024 Mar; 653():123919. PubMed ID: 38373598
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Radioactive Holmium-166 Microspheres for the Intratumoral Treatment of a Canine Pituitary Tumor.
Morsink NC; Klaassen NJM; Meij BP; Kirpensteijn J; Grinwis GCM; Schaafsma IA; Hesselink JW; Nijsen JFW; van Nimwegen SA
Front Vet Sci; 2021; 8():748247. PubMed ID: 34805338
[No Abstract] [Full Text] [Related]
5. Lung Mean Dose Prediction in Transarterial Radioembolization (TARE): Superiority of [
Wagemans MEHM; Braat AJAT; van Rooij R; Smits MLJ; Bruijnen RCG; Prince JF; Bol GM; de Jong HWAM; Lam MGEH
Cardiovasc Intervent Radiol; 2024 Apr; 47(4):443-450. PubMed ID: 38326577
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of
Bucalau AM; Collette B; Tancredi I; Vouche M; Pezzullo M; Bouziotis J; Moreno-Reyes R; Trotta N; Levillain H; Van Laethem JL; Verset G
Eur J Hybrid Imaging; 2023 Jul; 7(1):12. PubMed ID: 37414964
[TBL] [Abstract][Full Text] [Related]
7. Facile Preparation of Samarium Carbonate-Polymethacrylate Microspheres as a Neutron-Activatable Radioembolic Agent for Hepatic Radioembolization.
Wong YH; Kasbollah A; Abdullah BJJ; Yeong CH
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986738
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.
Alrfooh A; Patel A; Laroia S
Nucl Med Mol Imaging; 2021 Aug; 55(4):162-172. PubMed ID: 34422126
[TBL] [Abstract][Full Text] [Related]
9. Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects.
d'Abadie P; Hesse M; Louppe A; Lhommel R; Walrand S; Jamar F
Molecules; 2021 Jun; 26(13):. PubMed ID: 34209590
[TBL] [Abstract][Full Text] [Related]
10. The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review.
Barat M; Cottereau AS; Kedra A; Dermine S; Palmieri LJ; Coriat R; Dautry R; Tselikas L; Soyer P; Dohan A
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32698459
[TBL] [Abstract][Full Text] [Related]
11. Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors.
Wong YH; Tan HY; Kasbollah A; Abdullah BJJ; Acharya RU; Yeong CH
World J Exp Med; 2020 Mar; 10(2):10-25. PubMed ID: 32266125
[TBL] [Abstract][Full Text] [Related]
12. Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis.
Wong YH; Tan HY; Kasbollah A; Abdullah BJJ; Yeong CH
Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31718079
[TBL] [Abstract][Full Text] [Related]
13. The various therapeutic applications of the medical isotope holmium-166: a narrative review.
Klaassen NJM; Arntz MJ; Gil Arranja A; Roosen J; Nijsen JFW
EJNMMI Radiopharm Chem; 2019 Aug; 4(1):19. PubMed ID: 31659560
[TBL] [Abstract][Full Text] [Related]
14. Poly(3-hydroxi-butyrate-co-3-hydroxy-valerate) (PHB-HV) microparticles loaded with holmium acetylacetonate as potential contrast agents for magnetic resonance images.
de Azevedo MBM; Melo VH; Soares CR; Gamarra LF; Barros CH; Tasic L
Int J Nanomedicine; 2019; 14():6869-6889. PubMed ID: 31507318
[TBL] [Abstract][Full Text] [Related]
15. Transarterial Radioembolization (TARE) Agents beyond
Bouvry C; Palard X; Edeline J; Ardisson V; Loyer P; Garin E; Lepareur N
Biomed Res Int; 2018; 2018():1435302. PubMed ID: 30687734
[TBL] [Abstract][Full Text] [Related]
16. Neutron-activatable needles for radionuclide therapy of solid tumors.
Kim J; Narayan RJ; Lu X; Jay M
J Biomed Mater Res A; 2017 Dec; 105(12):3273-3280. PubMed ID: 28804994
[TBL] [Abstract][Full Text] [Related]
17. Neutron-activatable radionuclide cancer therapy using graphene oxide nanoplatelets.
Kim J; Jay M
Nucl Med Biol; 2017 Sep; 52():42-48. PubMed ID: 28624669
[TBL] [Abstract][Full Text] [Related]
18. Mechanical properties, in vitro corrosion and biocompatibility of newly developed biodegradable Mg-Zr-Sr-Ho alloys for biomedical applications.
Ding Y; Lin J; Wen C; Zhang D; Li Y
Sci Rep; 2016 Aug; 6():31990. PubMed ID: 27553403
[TBL] [Abstract][Full Text] [Related]
19. Intracavitary radiation therapy for recurrent cystic brain tumors with holmium-166-chico : a pilot study.
Ha EJ; Gwak HS; Rhee CH; Youn SM; Choi CW; Cheon GJ
J Korean Neurosurg Soc; 2013 Sep; 54(3):175-82. PubMed ID: 24278644
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.
Bult W; Kroeze SG; Elschot M; Seevinck PR; Beekman FJ; de Jong HW; Uges DR; Kosterink JG; Luijten PR; Hennink WE; van het Schip AD; Bosch JL; Nijsen JF; Jans JJ
PLoS One; 2013; 8(1):e52178. PubMed ID: 23320070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
